published meta-analysis   sensitivity analysis   studies

IFN gamma in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsEsquivel-Moynelo, 2020 1.10 [0.02; 57.31] 1.10[0.02; 57.31]Esquivel-Moynelo, 202010%63NAnot evaluable clinical deteriorationdetailed resultsEsquivel-Moynelo, 2020 2.29 [0.20; 26.58] 2.29[0.20; 26.58]Esquivel-Moynelo, 202010%63NAnot evaluable viral clearance detailed resultsEsquivel-Moynelo, 2020 3.26 [1.53; 6.95] 3.26[1.53; 6.95]Esquivel-Moynelo, 202010%63NAnot evaluable viral clearance (time to event analysis only)detailed resultsEsquivel-Moynelo, 2020 3.26 [1.53; 6.95] 3.26[1.53; 6.95]Esquivel-Moynelo, 202010%63NAnot evaluable viral clearance by day 14detailed resultsEsquivel-Moynelo, 2020 5.90 [0.28; 122.94] 5.90[0.28; 122.94]Esquivel-Moynelo, 202010%63NAnot evaluable viral clearance by day 7detailed resultsEsquivel-Moynelo, 2020 3.09 [1.04; 9.17] 3.09[1.04; 9.17]Esquivel-Moynelo, 202010%63NAnot evaluable adverse eventsdetailed resultsEsquivel-Moynelo, 2020 1.33 [0.45; 3.92] 1.33[0.45; 3.92]Esquivel-Moynelo, 202010%63NAnot evaluable0.510.01.0relative treatment effectwww.metaEvidence.org2024-04-28 10:29 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 897 - roots T: 290